Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone.
Jacobson
R H
RH
Wang
P
P
Glueck
C J
CJ
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008148:Lovastatin / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D009220:Myositis / Q000139:chemically induced*; D010879:Piperazines; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019821:Simvastatin; D014230:Triazoles / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D004791:Enzyme Inhibitors; D000960:Hypolipidemic Agents; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone; D008148:Lovastatin; D019821:Simvastatin